Boji Medical Technology Co.,Ltd. (SHE:300404)
China flag China · Delayed Price · Currency is CNY
12.68
-0.29 (-2.24%)
At close: Sep 2, 2026

Boji Medical Technology Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
52.6730.4928.7824.3427.6738.88
Depreciation & Amortization
27.7727.6427.2323.2521.517.88
Other Amortization
2.777.743.664.232.831.46
Loss (Gain) From Sale of Assets
--0.210--
Asset Writedown & Restructuring Costs
8.610.010.080.030.070.3
Loss (Gain) From Sale of Investments
-13.09-2.32-3.04-2.78-3.75-2.36
Provision & Write-off of Bad Debts
13.4426.4320.3815.3614.928.32
Other Operating Activities
4.877.718.587.627.277.79
Change in Accounts Receivable
-70.42-80.7-108.31-45.55-52.26-22.47
Change in Inventory
-1.84-41.948.24-33.51-23.49-56.55
Change in Accounts Payable
53.58124.1160.0857.0141.3538.69
Operating Cash Flow
68.8687.0126.7835.9528.1430.1
Operating Cash Flow Growth
59.26%224.90%-25.52%27.77%-6.52%-68.99%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-15.36-18.71-29.35-62.2-117.73-53.99
Sale of Property, Plant & Equipment
0.0100.460.010.010.11
Investment in Securities
102.65-29.91-40.9826.42-47.71-42.13
Other Investing Activities
-60.182.213.022.683.412.49
Investing Cash Flow
27.13-46.4-66.85-33.1-162.02-93.52

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-44.888.3356.0275.3125.13
Total Debt Issued
7.7544.888.3356.0275.3125.13
Long-Term Debt Repaid
--47.68-75.61-27.71-28.67-33.79
Total Debt Repaid
-10.1-47.68-75.61-27.71-28.67-33.79
Net Debt Issued (Repaid)
-2.35-2.8-67.2928.3146.64-8.66
Issuance of Common Stock
14.4226.313.3594.5912.14348.2
Repurchase of Common Stock
---15.65---
Common Dividends Paid
-10.79-5.92-7.58-8.04-6.84-1.2
Other Financing Activities
23.18-0.650.18-27.93-0.53-35.94
Financing Cash Flow
24.4516.93-86.9886.9351.41302.4

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-1.49-0.660.460.452.88-0.84
Net Cash Flow
118.9456.87-126.690.23-79.59238.14

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
53.568.3-2.57-26.24-89.59-23.89
Free Cash Flow Growth
110.70%-----
Free Cash Flow Margin
5.56%7.86%-0.35%-4.72%-21.15%-7.37%
Free Cash Flow Per Share
0.140.18-0.01-0.07-0.24-0.07
Levered Free Cash Flow
48.4858.633.33-47.08-106.39-62.77
Unlevered Free Cash Flow
48.9659.685.32-46.12-105.95-61.9

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
57.8448.1338.9621.6710.1911.85
Change in Working Capital
-28.19-10.68-59.1-36.1-42.36-42.18